Inactive Instrument

News ZS Pharma Inc

Equities

US98979G1058

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2016	AstraZeneca : potassium drug delayed by manufacturing snag	RE
2015	AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug	RE

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AstraZeneca : potassium drug delayed by manufacturing snag	27/05/16	RE
ZS Pharma : AstraZeneca completes acquisition of ZS Pharma	22/12/15	PU
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug	17/12/15	RE
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug	17/12/15	RE
AbbVie : AstraZeneca chases Acerta to secure next cancer drug winner	14/12/15	RE
AstraZeneca : in talks to buy cancer drugmaker Acerta for $5 billion: WSJ	11/12/15	RE
ZS Pharma Announces New Employment Inducement Grants	09/12/15	GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	12/11/15	BU
ZS PHARMA : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with AstraZeneca PLC	11/11/15	BU
ZS Pharma Announces New Employment Inducement Grants	10/11/15	GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Investors To Contact The Firm For Additional Information	10/11/15	BU
ZS Pharma Announces Positive Interim Results From a Long-Term Safety Study of ZS-9	07/11/15	GL
Wall St. flat as rate hike eyed; banks counter utilities drop	06/11/15	RE
Actelion : AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion	06/11/15	RE
Actelion : raises 2015 earnings forecast after strong drug sales	20/10/15	RE
ZS Pharma Announces Upcoming Poster Presentation of Interim Results From Its Long-Term Safety Study of ZS-9	19/10/15	GL
ZS Pharma Corporate Statement	10/09/15	GL
ZS Pharma Reports Second Quarter 2015 Financial Results and Provides Corporate Update	06/08/15	GL
ZS Pharma Announces FDA Acceptance of ZS-9 New Drug Application	29/07/15	GL
ZS Pharma Announces Participation at Upcoming Investor Conferences	28/05/15	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ZS Pharma Inc

Equities

US98979G1058

Summary

Filters